The new health and beauty care standouts of 2003

Zepbound from Eli Lilly is the first and only prescription medicine approved by the FDA for adults with obstructive sleep apnea and obesity.

Episode 8 of Over the Counter discusses the new and exciting modernizations in the medication decision support space.

Vtama from Organon was previously approved in May 2022 to treat plaque psoriasis in adults.

Catch up on important FDA news from the week of December 2.

This approval marks the availability of the first near-complete stabilizer of transthyretin.

The agency assigned prademagene zamikeracel a PDUFA target action date of April 29, 2025.